Want a Replacement for 2D Gels? Target Discovery Says CE/MS May Offer the Answer | GenomeWeb

After helping start several companies while at the Stanford Research Institute, Luke Schneider finally decided five years ago that it was time to go out and do his own thing. He figured proteomics would be his best bet, not only because it was fairly new, but also because he had first-hand experience with the frustrations of running 2D gels and realized there was room for a company offering an alternative.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.